Wyeth Licenses Interleukin Receptor Patents from ZymoGenetics
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 27 (Table of Contents)
Published: 2 Aug-2002
DOI: 10.3833/pdr.v2002.i27.1020 ISSN: 1756-7874
Section: Licensing
Abstract
Wyeth licensed two US patent applications for Interleukin-13 receptor subunit (IL-13R alpha2), also known as WSX-II, from ZymoGenetics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS